Matthew Warburton

Matthew Warburton is an experienced Market Access Leader with significant experience leading biotech and pharmaceutical brands to successful pre-launch, launch and market outcomes. Deep expertise across all payer-related market access and patient reimbursement dynamics including pharmacy, medical models, specialty distribution systems and support hubs.

Matthew is responsible for strategic planning recommendations relating to payer strategy, pricing and reimbursement, as well as discovering the essential elements that create value, value proposition and access strategies. Matthew also Develops integrated access strategies that reflect macro (health care reform) and disease specific factors (such as clinical profile, market segmentation, disease staging, clinical pathway and country launch sequencing), with KPIs to evaluate success

Close ()